Salim Syed
Stock Analyst at Mizuho
(0.83)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NKTX Nkarta | Maintains: Outperform | 16 14 | 2 | 600% | 8 | Jun 10, 2025 | |
CYTK Cytokinetics | Maintains: Outperform | 103 84 | 33.2 | 153.01% | 7 | May 29, 2025 | |
BIIB Biogen | Maintains: Outperform | 207 169 | 128.03 | 32% | 16 | May 7, 2025 | |
AMGN Amgen | Maintains: Neutral | 235 280 | 285.1 | -1.79% | 8 | May 7, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 100 117 | 120.57 | -2.96% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 22 | 8.11 | 171.27% | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 113 163 | 29.7 | 448.82% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 18 | 10.4 | 73.08% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 18.11 | 87.74% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 82 99 | 55.44 | 78.57% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 53 | 48.24 | 9.87% | 7 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | n/a | n/a | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 0.88 | 2286.36% | 5 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 168 36 | 23.54 | 52.93% | 1 | Nov 16, 2022 |